| |
|
|
|
CfPA-The Center for Professional Advancement, Burlingame, CA
August 18, 2017
Who Should Attend?
This course is intended for professionals in the Pharmaceutical, Food and Dietary Supplement industries that require a complete and thorough knowledge of granulation technology.
Participants are presumed to have some knowledge of basic granulation and want to gain additional knowledge for selecting the appropriate technologies for the intended product design and to trouble shoot the granulation process.
Those who have gained valuable information from this course include:
• R&D Scientists
• Technical Services Engineer/Managers
• Quality Assurance
• Solid Dosage Line Management
• Regulatory Affairs Specialists Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
| Course Director |  | Dilip M. Parikh; President and CEO, DPharma Group Inc. |
Dilip M. Parikh is a President and CEO of DPharma Group Inc. a Pharmaceutical Technology consulting organization. Previously, he was the Vice President with Synthon Pharmaceuticals Ltd., and Vice President and General Manager of Atlantic Pharmaceutical Services, Inc and was Manager of Process Technology with Niro Inc. His previous experience was with Sandoz (Canada), McNeil and Ortho Pharmaceutical in Canada and the US, and other pharmaceutical companies. Mr. Parikh has over 35 years of varied experience in the pharmaceutical industry ranging from product development, manufacturing, regulatory affairs, and operational management.
He has been an invited speaker at various scientific conferences worldwide on solid dosage manufacturing technologies, modified release dosage forms, fluid bed and spray drying technologies, contract development and manufacturing, and pre-approval inspections. He is on the editorial board of Contract Pharma Journal and has published several papers on these subjects. He is the editor of Handbook of Pharmaceutical Granulation Technology and has published two chapters in both Pharmaceutical Process Scale- Up and Pharmaceutical Process Validation.
Additional Faculty
Dr. Cecil W. Propst is Managing Director, Propst Consulting Services. He was Director of R&D (Grand Haven site) at SPI Pharma until semi retirement in 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SPAC contract with the FDA.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
Jmorbit@cfpa.com
|
|
|
|
|
|
|
|
|